Aboriginal way of life and cancer diagnosis
Roslyn Weetra, an Aboriginal Elder and cancer survivor, discusses her experience with cancer being a member of the Australian aboriginal community. She was diagnosed with non-Hodgkins lymphoma and re... Author: VJOncology Added: 12/09/2016 (Source: Oncology Tube)
Source: Oncology Tube - December 9, 2016 Category: Cancer & Oncology Source Type: podcasts

CLL and Non Hodgkin Lymphoma: What new drugs are on the horizon and why are they exciting?
John Kuruvilla, MD, Associate Professor, Princess Margaret Hospital, University Health Network in Toronto, Canada, spoke with GRACE about Chronic Lymphocytic Leukemia (CLL) and Non Hodgkin Lymphoma, ... Author: cancergrace Added: 09/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 13, 2016 Category: Cancer & Oncology Source Type: podcasts

TGR-1202 in CLL and Non-Hodgkin lymphoma
Howard Burris, MD from Sarah Cannon, Nashville, TN discusses TGR-1202 for chronic lymphocytic leukemia (CLL) and Non-Hodgkin lymphoma (NHL). TGR-1202 is a PI3K delta inhibitor and Dr Burris discusses ... Author: VJHemOnc Added: 07/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2016 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Emerging monoclonal antibodies for lymphoma therapy
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Thomas J. Kipps, MD, PhD, of the University of California, San Diego, San Diego, CA, discusses novel monoclonal antibodies a... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Approaches to overcome side effects of idelalisib for follicular lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, discusse... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Combination studies with venetoclax (ABT-199), BCL-2 inhibitor, for non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Michael E. Williams, MD, of the University of Virginia School of Medicine, Charlottesville, VA, discusses the clinical devel... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Determining effective combinations of immune checkpoint inhibitors for lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Stephen M. Ansell, MD, PhD, of Mayo Clinic, Rochester, MN, discusses the clinical development of combination approaches with... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Duvelisib, dual inhibitor of PI3K delta and PI3K gamma, for indolent non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Ian Flinn, MD, of Tennessee Oncology, Nashville, TN, discusses the clinical development of duvelisib, a dual inhibitor of ph... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Ibrutinib, Bruton’s tyrosine kinase inhibitor, for non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Thomas J. Kipps, MD, PhD, of the University of California, San Diego, San Diego, CA, discusses the currently available data ... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Monoclonal antibody therapies for cutaneous T-cell lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Pier Luigi Zinzani, MD, PhD, of University of Bologna, Bologna, Italy, discusses the clinical development of the anti-CD30 a... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Selinexor, selective inhibitor of nuclear export, for non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, John Kuruvilla, MD, of Princess Margaret Cancer Centre, Toronto, Canada, discusses the early clinical activity of selinexor,... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: TGR-1202, novel PI3K delta inhibitor, for hematological malignancies
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Owen A. O'Connor, MD, PhD, of Columbia University, New York, NY, discusses TGR-1202, a novel phosphoinositide 3-kinase (PI3K... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Therapeutic opportunities for lenalidomide in non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Nathan H. Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the ongoing clinical tria... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Biology of diffuse large B-cell lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Catherine M. Bollard, MBChB, MD, FRACP, FRCPA, of Children's National Health System and The George Washington University, Wa... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts